Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 15 years, with Q2 2025 value amounting to $15.2 million.

  • Lifecore Biomedical, Inc. \De\'s Receivables - Net fell 690.06% to $15.2 million in Q2 2025 from the same period last year, while for May 2025 it was $15.2 million, marking a year-over-year decrease of 690.06%. This contributed to the annual value of $15.2 million for FY2025, which is 690.06% down from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical, Inc. \De\'s Receivables - Net is $15.2 million, which was down 690.06% from $16.1 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s Receivables - Net's 5-year high stood at $39.7 million during Q1 2022, with a 5-year trough of $15.2 million in Q2 2025.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Receivables - Net had a median value of $27.5 million in 2021 and averaged $26.2 million.
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Receivables - Net tumbled by 5862.71% in 2021 and then surged by 6303.94% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Receivables - Net (Quarter) stood at $27.5 million in 2021, then decreased by 0.13% to $27.5 million in 2022, then fell by 29.23% to $19.4 million in 2023, then skyrocketed by 58.84% to $30.9 million in 2024, then crashed by 50.91% to $15.2 million in 2025.
  • Its Receivables - Net stands at $15.2 million for Q2 2025, versus $16.1 million for Q1 2025 and $30.9 million for Q4 2024.